top of page
Search

In-Vitro Diagnostics (IVD) Market Insights: Size, Share & Forecast 2032

  • Writer: Pallavi Garudkar
    Pallavi Garudkar
  • Jan 7
  • 2 min read
In-Vitro Diagnostics (IVD) Market
In-Vitro Diagnostics (IVD) Market

According to Fortune Business Insights the global in-vitro diagnostics (IVD) market size was valued at USD 77.73 billion in 2025 and is expected to grow from USD 81.83 billion in 2026 to USD 135.65 billion by 2034, exhibiting a CAGR of 6.50% during the forecast period. The In-Vitro Diagnostics (IVD) Market comprises medical tests performed on biological samples such as blood, urine, tissue, and saliva outside the human body. These tests are essential for disease diagnosis, monitoring, screening, and therapeutic decision-making across healthcare systems.

IVD solutions are widely used in hospitals, clinical laboratories, diagnostic centers, and point-of-care settings, supporting early disease detection, personalized medicine, and preventive healthcare. Continuous innovation in diagnostic technologies has strengthened the role of IVD in modern clinical practice.

Market Drivers

  • Rising prevalence of chronic and infectious diseases

  • Growing emphasis on early and accurate diagnosis

  • Increasing demand for preventive healthcare and routine testing

  • Rapid advancements in molecular diagnostics and immunoassays

  • Expansion of healthcare infrastructure in emerging economies

  • Rising adoption of point-of-care (POC) diagnostic solutions

Market Segmentation

By Product & Service

  • Reagents & Kits (largest share due to repeat usage)

  • Instruments

  • Software & Diagnostic Services

By Technology

  • Immunoassays (dominant segment)

  • Molecular Diagnostics

  • Clinical Chemistry

  • Hematology

  • Glucose Monitoring

  • Microbiology & Other Technologies

By Application

  • Infectious Diseases

  • Oncology

  • Cardiology

  • Endocrinology

  • Neurology

  • Other Clinical Applications

By Site of Testing

  • Centralized Diagnostic Laboratories

  • Hospital & Clinic Laboratories

  • Point-of-Care Testing Locations

Regional Insights

  • North America leads the market due to advanced healthcare infrastructure, high diagnostic spending, and rapid technology adoption

  • Europe holds a significant share supported by an aging population and well-established laboratory networks

  • Asia Pacific is the fastest-growing region driven by expanding healthcare access, rising disease burden, and government healthcare initiatives

  • Latin America and Middle East & Africa are emerging markets with improving diagnostic infrastructure and growing awareness

Competitive Landscape

The IVD market is highly competitive, with key players focusing on innovation, automation, and expansion into emerging markets.

Major companies include:

  • F. Hoffmann-La Roche Ltd. (Switzerland)

  • Abbott (U.S.)

  • Thermo Fisher Scientific Inc.  (U.S.)

  • Sysmex Corporation (Japan)

  • Siemens Healthineers AG (Germany)

  • BD (U.S.)

  • Seegene Inc. (Republic of Korea)

  • DiaSorin S.p.A. (Italy)

Key Industry Development:

  • February 2024 – Thermo Fisher Scientific Inc. launched a new ion chromatography instrument to improve the reliability, efficiency, and functional adaptability of labs.

  • December 2023 – Thermo Fisher Scientific Inc. signed a distribution agreement with AESKU GROUP GmbH, a provider of innovative diagnostic solutions, to market IFA testing kits and instruments in the U.S.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights Pvt. Ltd.

9th Floor, Icon Tower,

Baner - Mahalunge Road, Baner,

Pune-411045, Maharashtra, India.

Phone:

US: +18339092966

UK: +448085020280

APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.com


 
 
 

Comments

bottom of page